RIGEL PHARMACEUTICALS $3.85

up +0.08


19/6/2013 04:19 PM  |  NASDAQ : RIGL  |  Industries : Manufacturing / Pharmaceutical and Medicine Manufacturing
Last Trade: 3.85
Trade Time: Jun 19 4:05 PM Eastern Daylight Time
Change: 0.08 (2.12 %)
Prev Close: 3.77
Open: 3.76
Bid: 3.85
Ask: 3.86
Quotes displayed are delayed by 15 minutes. Market data is provided by Telvent DTN
Get Trend Analysis Icon Get RIGL Trend Analysis - it has underperformed the S&P 500 by 77%

ETF Alternatives



People viewing RIGL also viewed: , , , ,

Competitors

Ticker Name Volume % Change
ACEL TAMIR BIOTECHNOLOGY 5.5K +1.50%
WPHM WINSTON PHARMACEUTICALS 20.0K +1.50%
CKGT CHINA KANGTAI CACTUS BIO 500.0 +1.11%
MLGGY MELDEX INTERNATIONAL 300.0 +1.00%
PARS PHARMOS 3.2K +0.73%

Insider Transactions

Date Name Title Volume Trade Price Holding Change
6/7/2013 BVF PARTNERS L P/IL Substantial Shareholder 24,598 $3.47 1.72%
6/7/2013 BVF PARTNERS L P/IL Substantial Shareholder 8,102 $3.47 1.02%
9/13/2012 VANCE DOLLY EVP Corp. Affairs, G.C., Sect. -4,151 $10.43 -79.01%
9/12/2012 Maynard Ryan D EVP & CFO -23,302 $10.67 -100.00%
9/10/2012 Maynard Ryan D EVP & CFO -17,586 $10.52 -100.00%
Data provided by Insiderslab.com. To read detailed Insider Trading Research Report for (RIGL), click here.
View All

RIGL Stock Analysis

  1. Market Wrap for Tuesday, June 4: Stocks Retreat as Uncertainty Rises

    (AZN,CG,CRM,DG,ET,GIII,MHGC,MNST,RIGL,SLCA,SPY,TLT,UUP )
    Stocks fell on Tuesday, although a late day rally lifted share prices off of their worst levels of the session. The move lower comes as volatility has picked up in the U.S. stock market after a torrid rally to start 2013. A series of mediocre economic reports and uncertainty over the future course of Federal Reserve policy has caused investors to re-assess risk levels in recent days.Although the market's upward trajectory appears to still be intact, bouts of profit taking could make for choppy trading in coming weeks.
Free Reports
  1.

    View the Portfolios of the Worlds Top Investors, FREE!

    Learn from Warren Buffett, George Soros and More!
  2.

    Free Investment Report: 6 Must-Own Emerging Market Stocks

    Gain Valuable Insights into International and Emerging Markets That are Poised for Explosive Growth!
  3.

    Forbes Wolfe Nanotech Report Nanotech 101

    Get this Rare, First-Person Account of the Nanotechnology Industry, Absolutely Free!
Marketplace
Trading Center